AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUN 4 - (NewsRx.com & NewsRx.net) -- The pneumococcal conjugate vaccine reduced mortality from pneumococcal infection in children in Brazil.
According to recent research from Brazil, "The distribution of pneumococcal serotypes in Brazil was analyzed by age group and clinical diagnosis, using data obtained during 20 years of national surveillance."
"Serotypes 1 and 5 remained among the main serotypes in all age groups, increasing in frequency with age," reported Maria-Cristina C. Brandileone and colleagues at the Adolfo Lutz Institute and the Federal University of Goias. "Serotype 14 was prevalent among children, whereas serotypes 3 and 4 were most prevalent among the adult population. The potential impact of the 7- and 9-valent conjugate vaccines on children up to age five years with severe pneumococcal diseases was 58.2% and 73%, respectively; the highest coverage of the 7-valent vaccine for pneumonia was achieved for children aged seven months to two years (70%), whereas, for meningitis, it was observed for children aged seven months to five years (58.6%)."
The researchers ...